David Block
Directeur Général chez Gliknik, Inc.
Postes actifs de David Block
Sociétés | Poste | Début | Fin |
---|---|---|---|
Gliknik, Inc.
Gliknik, Inc. Pharmaceuticals: MajorHealth Technology Gliknik, Inc. discovers and develops biotechnology drugs for autoimmune diseases and cancer. The company was founded by David S. Block and Scott E. Strome in 2007 and is headquartered in Baltimore, MD. | Directeur Général | - | - |
Président | 01/01/2007 | - | |
Fondateur | 01/01/2007 | - | |
President | 01/01/2007 | - |
Historique de carrière de David Block
Anciens postes connus de David Block
Sociétés | Poste | Début | Fin |
---|---|---|---|
COCRYSTAL PHARMA, INC. | Directeur/Membre du Conseil | 25/11/2014 | 04/01/2019 |
Independent Dir/Board Member | 25/11/2014 | 04/01/2019 | |
Celera Group
Celera Group Pharmaceuticals: MajorHealth Technology Celera Group provides molecular diagnostics using proprietary genomics and proteomics discovery platforms to identify and validate novel diagnostic markers and to develop diagnostic products based on these markers. These diagnostic products are used to predict disease risk and optimize therapy selection, monitoring and patient outcome. The company was founded in May, 1998 and is located in Rockville, MD | Directeur des opérations | 01/01/2002 | 01/01/2004 |
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | Directeur des opérations | - | - |
Tech Council of Maryland, Inc.
Tech Council of Maryland, Inc. Miscellaneous Commercial ServicesCommercial Services Tech Council of Maryland, Inc. provides membership association services for technology and life science communities. The firm serves the advanced technology and biotechnology communities. The company was founded in 1986 and is headquartered in Rockville, MD. | Directeur/Membre du Conseil | 24/05/2011 | - |
DuPont Merck Pharmaceutical Co.
DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Directeur des opérations | 12/12/2012 | - |
Psyadon Pharmaceuticals, Inc.
Psyadon Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Psyadon Pharmaceuticals, Inc. specializes in the development of drugs for central nervous system diseases. Its ecopipam product is an antagonist of the d1 dopamine receptor that blocks the actions of the neurotransmitter dopamine at the d1 receptor-family in the brain. The firm focuses its efforts on drugs for orphan indications because of the high medical need for effective treatments in these areas. The company was founded by Jeffrey D. Rothstein and David S. Block in 2004 and is headquartered in Germantown, MD. | Directeur Général | 01/01/2004 | - |
Fondateur | 01/01/2004 | - | |
President | 04/06/2010 | - |
Formation de David Block
University of Pennsylvania | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 9 |
Opérationnelle
Chief Operating Officer | 3 |
Chief Executive Officer | 2 |
Founder | 2 |
Sectorielle
Health Technology | 6 |
Retail Trade | 2 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
COCRYSTAL PHARMA, INC. | Health Technology |
Entreprise privées | 6 |
---|---|
Psyadon Pharmaceuticals, Inc.
Psyadon Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Psyadon Pharmaceuticals, Inc. specializes in the development of drugs for central nervous system diseases. Its ecopipam product is an antagonist of the d1 dopamine receptor that blocks the actions of the neurotransmitter dopamine at the d1 receptor-family in the brain. The firm focuses its efforts on drugs for orphan indications because of the high medical need for effective treatments in these areas. The company was founded by Jeffrey D. Rothstein and David S. Block in 2004 and is headquartered in Germantown, MD. | Retail Trade |
Gliknik, Inc.
Gliknik, Inc. Pharmaceuticals: MajorHealth Technology Gliknik, Inc. discovers and develops biotechnology drugs for autoimmune diseases and cancer. The company was founded by David S. Block and Scott E. Strome in 2007 and is headquartered in Baltimore, MD. | Health Technology |
DuPont Merck Pharmaceutical Co.
DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Health Technology |
Celera Group
Celera Group Pharmaceuticals: MajorHealth Technology Celera Group provides molecular diagnostics using proprietary genomics and proteomics discovery platforms to identify and validate novel diagnostic markers and to develop diagnostic products based on these markers. These diagnostic products are used to predict disease risk and optimize therapy selection, monitoring and patient outcome. The company was founded in May, 1998 and is located in Rockville, MD | Health Technology |
Tech Council of Maryland, Inc.
Tech Council of Maryland, Inc. Miscellaneous Commercial ServicesCommercial Services Tech Council of Maryland, Inc. provides membership association services for technology and life science communities. The firm serves the advanced technology and biotechnology communities. The company was founded in 1986 and is headquartered in Rockville, MD. | Commercial Services |
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | Health Technology |
- Bourse
- Insiders
- David Block
- Expérience